RNU6-956P

Across TCGA pan-cancer cohorts, RNU6-956P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-956P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-956P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-956P expression acts as an unfavorable survival marker, although some lineages such as PAAD and ESCA show a favorable association.

UCEC, LUSC, and CESC are the cancer types where RNU6-956P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.820	0.931	<.001	102	view →
LUSC	DFS	Tertile	All	0.139	0.707	.022	36	view →
CESC	OS	Tertile	II,III,IV	0.524	0.829	.045	18	view →
KIRP	OS	Tertile	All	0.516	0.743	.004	15	view →
GBM	DFS	Tertile	All	0.114	0.251	.014	9	view →
SARC	DFS	Tertile	All	0.118	0.591	.034	9	view →
PAAD	DFS	Tertile	II,III,IV	1.000	0.263	.037	6	view →
ESCA	DFS	Tertile	III,IV	0.769	0.281	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-956P–UCEC (OS)

Open the UCEC breakdown →